CTLA-4 regulates human Natural Killer cell effector functions

Affiliations

¹ Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, Department of Clinical and Experimental Sciences, University of Brescia and ASST-Spedali Civili of Brescia, Italy. Electronic address: vassilios.lougaris@unibs.it.
² Department of Molecular and Translational Medicine, University of Brescia, Italy.
³ Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, Department of Clinical and Experimental Sciences, University of Brescia and ASST-Spedali Civili of Brescia, Italy.
⁴ Center for Chronic Immunodeficiency (CCI), University Medical Center Freiburg and University of Freiburg, Freiburg 79106, Germany.
⁵ Department of Internal Medicine, Rheumatology Unit, San Gerardo Hospital, Monza, Italy.

Vassilios Lougaris et al. Clin Immunol. 2018 Sep.

. 2018 Sep:194:43-45.

doi: 10.1016/j.clim.2018.06.010. Epub 2018 Jun 30.

¹ Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, Department of Clinical and Experimental Sciences, University of Brescia and ASST-Spedali Civili of Brescia, Italy. Electronic address: vassilios.lougaris@unibs.it.
² Department of Molecular and Translational Medicine, University of Brescia, Italy.
³ Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, Department of Clinical and Experimental Sciences, University of Brescia and ASST-Spedali Civili of Brescia, Italy.
⁴ Center for Chronic Immunodeficiency (CCI), University Medical Center Freiburg and University of Freiburg, Freiburg 79106, Germany.
⁵ Department of Internal Medicine, Rheumatology Unit, San Gerardo Hospital, Monza, Italy.

No abstract available

Keywords: CTLA-4; CVID; Cytotoxic activity; IFN-γ; NK cells.

Publication types